Not applicableLooking for participantsNCT06192576
What this trial is testing
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
Who this might be right for
Niemann-Pick DiseasesAcid Sphingomyelinase Deficiency
Sanofi 10